Considerable decline in prostate cancer mortality in Nordic countries after 2000

Background and purpose: In the late 1990s, the Nordic countries, with Norway at the top, were among the countries with the highest prostate cancer mortality in the world. We present updated mortality rates from the Nordic countries and discuss possible interpretations of changes in trends. Material...

Full description

Saved in:
Bibliographic Details
Main Authors: Rune Kvåle, Giske Ursin, Christian Ekanger, Bjørn Møller
Format: Article
Language:English
Published: Medical Journals Sweden 2025-01-01
Series:Acta Oncologica
Subjects:
Online Access:https://medicaljournalssweden.se/actaoncologica/article/view/41334
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583804414328832
author Rune Kvåle
Giske Ursin
Christian Ekanger
Bjørn Møller
author_facet Rune Kvåle
Giske Ursin
Christian Ekanger
Bjørn Møller
author_sort Rune Kvåle
collection DOAJ
description Background and purpose: In the late 1990s, the Nordic countries, with Norway at the top, were among the countries with the highest prostate cancer mortality in the world. We present updated mortality rates from the Nordic countries and discuss possible interpretations of changes in trends. Material and methods: Age-standardized rates for prostate-specific mortality in 1985–2022, estimated lifetime risk of death (0–84 years) and annual changes in mortality were obtained from the NORDCAN database. Joinpoint regression was used to evaluate trend changes for the period 1985–2022. For comparison, rates from other European countries from 2022 were retrieved from the GLOBOCAN database. Results: Between 1995–99 and 2018–22, mortality in men aged 40–84 years decreased from 38% in Denmark to 59% in Norway. By 2022 Norway had the second lowest mortality among the Nordic countries overall, and the lowest under 85 years. The life-time risk of dying from prostate cancer declined from 5.6–7.1% in 1995–99 to 3.1–4.2% in the last 5-year period. During the last years mortality has decreased most rapidly in Sweden (4.5% annually from 2016) and Norway (4.3% annually from 2014). The Nordic countries are no longer among the countries with the highest mortality in Europe. Interpretation: Mortality from prostate cancer has decreased significantly in the Nordic countries over the last decades. Possible explanatory factors are likely to include improvements in prostate cancer management strategies and treatment.
format Article
id doaj-art-ab16b6cf3963429289010beabd3f4a7a
institution Kabale University
issn 1651-226X
language English
publishDate 2025-01-01
publisher Medical Journals Sweden
record_format Article
series Acta Oncologica
spelling doaj-art-ab16b6cf3963429289010beabd3f4a7a2025-01-28T06:40:52ZengMedical Journals SwedenActa Oncologica1651-226X2025-01-016410.2340/1651-226X.2025.41334Considerable decline in prostate cancer mortality in Nordic countries after 2000Rune Kvåle0https://orcid.org/0000-0002-4106-230XGiske Ursin1https://orcid.org/0000-0002-0835-9507Christian Ekanger2https://orcid.org/0000-0002-6526-7174Bjørn Møller3https://orcid.org/0000-0002-4770-1889Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, NorwayCancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USADepartment of Oncology and Medical Physics, Haukeland University Hospital, Bergen, NorwayCancer Registry of Norway, Norwegian Institute of Public Health, Oslo, NorwayBackground and purpose: In the late 1990s, the Nordic countries, with Norway at the top, were among the countries with the highest prostate cancer mortality in the world. We present updated mortality rates from the Nordic countries and discuss possible interpretations of changes in trends. Material and methods: Age-standardized rates for prostate-specific mortality in 1985–2022, estimated lifetime risk of death (0–84 years) and annual changes in mortality were obtained from the NORDCAN database. Joinpoint regression was used to evaluate trend changes for the period 1985–2022. For comparison, rates from other European countries from 2022 were retrieved from the GLOBOCAN database. Results: Between 1995–99 and 2018–22, mortality in men aged 40–84 years decreased from 38% in Denmark to 59% in Norway. By 2022 Norway had the second lowest mortality among the Nordic countries overall, and the lowest under 85 years. The life-time risk of dying from prostate cancer declined from 5.6–7.1% in 1995–99 to 3.1–4.2% in the last 5-year period. During the last years mortality has decreased most rapidly in Sweden (4.5% annually from 2016) and Norway (4.3% annually from 2014). The Nordic countries are no longer among the countries with the highest mortality in Europe. Interpretation: Mortality from prostate cancer has decreased significantly in the Nordic countries over the last decades. Possible explanatory factors are likely to include improvements in prostate cancer management strategies and treatment. https://medicaljournalssweden.se/actaoncologica/article/view/41334Prostate cancerNordic countriesMortality trends
spellingShingle Rune Kvåle
Giske Ursin
Christian Ekanger
Bjørn Møller
Considerable decline in prostate cancer mortality in Nordic countries after 2000
Acta Oncologica
Prostate cancer
Nordic countries
Mortality trends
title Considerable decline in prostate cancer mortality in Nordic countries after 2000
title_full Considerable decline in prostate cancer mortality in Nordic countries after 2000
title_fullStr Considerable decline in prostate cancer mortality in Nordic countries after 2000
title_full_unstemmed Considerable decline in prostate cancer mortality in Nordic countries after 2000
title_short Considerable decline in prostate cancer mortality in Nordic countries after 2000
title_sort considerable decline in prostate cancer mortality in nordic countries after 2000
topic Prostate cancer
Nordic countries
Mortality trends
url https://medicaljournalssweden.se/actaoncologica/article/view/41334
work_keys_str_mv AT runekvale considerabledeclineinprostatecancermortalityinnordiccountriesafter2000
AT giskeursin considerabledeclineinprostatecancermortalityinnordiccountriesafter2000
AT christianekanger considerabledeclineinprostatecancermortalityinnordiccountriesafter2000
AT bjørnmøller considerabledeclineinprostatecancermortalityinnordiccountriesafter2000